semaglutide compounding ending Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s Makers of compounded Wegovy, Ozempic

Meet our doctors Last reviewed: 19 Jun 2026 Sources Glucagon-like peptide-1 (GLP-1): a gut hormone of potential interest in the treatment of diabetes, Bioessays [accessed 05 March 2026] Obesity Treatment (2023), NHS [accessed 05 March 2026] Semaglutide, National Institute for Health and Care Excellence [accessed 05 March 2026] Wegovy dosing schedule, Wegovy.com [accessed 05 March 2026] Wegovy (semaglutide): a new weight loss drug for chronic weight management, BMJ [accessed 05 March 2026] Weight loss injections NHS weight loss injections GLP-1 for weight loss Can doctors help with weight loss

Understanding the complete comparison of GLP-1 programs includes verifying state compliance

citizenship or legal residency, and no insurance coverage for Wegovy

Very low calorie diets (VLCDs), by contrast, produce the worst body composition outcomes